![](https://cdn1.poz.com/149444_P06-21-029.jpg_1c90707e-8d10-4bd3-a076-462f214d57b1_x2.jpeg)
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
[On June 26], the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity …